- Home
- RCON vs PROK Comparison
RCON vs PROK Comparison
Compare RCON & PROK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RCON
- PROK
- Stock Information
- Founded
- RCON 2007
- PROK 2015
- Country
- RCON China
- PROK United States
- Employees
- RCON N/A
- PROK N/A
- Industry
- RCON Oilfield Services/Equipment
- PROK Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- RCON Energy
- PROK Health Care
- Exchange
- RCON Nasdaq
- PROK Nasdaq
- Market Cap
- RCON 82.1M
- PROK 85.5M
- IPO Year
- RCON 2009
- PROK N/A
- Fundamental
- Price
- RCON $2.53
- PROK $3.27
- Analyst Decision
- RCON
- PROK Buy
- Analyst Count
- RCON 0
- PROK 5
- Target Price
- RCON N/A
- PROK $6.25
- AVG Volume (30 Days)
- RCON 19.9K
- PROK 37.1M
- Earning Date
- RCON 07-29-2025
- PROK 08-08-2025
- Dividend Yield
- RCON N/A
- PROK N/A
- EPS Growth
- RCON N/A
- PROK N/A
- EPS
- RCON N/A
- PROK N/A
- Revenue
- RCON $8,996,572.00
- PROK $306,000.00
- Revenue This Year
- RCON N/A
- PROK $85.21
- Revenue Next Year
- RCON $12.17
- PROK N/A
- P/E Ratio
- RCON N/A
- PROK N/A
- Revenue Growth
- RCON N/A
- PROK N/A
- 52 Week Low
- RCON $1.39
- PROK $0.46
- 52 Week High
- RCON $3.70
- PROK $7.13
- Technical
- Relative Strength Index (RSI)
- RCON 53.18
- PROK 62.08
- Support Level
- RCON $2.21
- PROK $3.17
- Resistance Level
- RCON $2.68
- PROK $4.05
- Average True Range (ATR)
- RCON 0.17
- PROK 1.00
- MACD
- RCON -0.02
- PROK 0.13
- Stochastic Oscillator
- RCON 61.76
- PROK 43.10
About RCON Recon Technology Ltd.
Recon Technology Ltd is an oilfield service company. The company is engaged in providing oilfield automation products, specialized equipment for oil and gas production and transportation, chemicals, and field services to petroleum companies mainly in the People's Republic of China (PRC). It has four reportable operating segments: Automation Product and Software, Equipment and Accessories, Platform outsourcing services, and Oilfield Environmental Protection. The majority of the firm's revenue comes from the Automation Product and Software segment which provides products and services like pumping unit controllers, natural gas flow computer systems, wireless dynamometers and wireless pressure gauges, and an oilfield monitor and data acquisition system among others.
About PROK ProKidney Corp.
ProKidney Corp is a clinical-stage biotechnology company with a transformative proprietary cell therapy platform capable of treating multiple chronic kidney diseases using a patient's cells isolated from the patient intended for treatment. Its product candidate, REACT (Renal Autologous Cell Therapy) is a disease-modifying cell therapy made from a patient's renal cells. REACT has the potential to slow and stabilize the progression of chronic kidney disease. The company's pipeline consists of the development program for severe diabetic kidney disease.